Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2701 AL 2715

RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia-an international Delphi consensus

O'Brien JT, Chouliaras L, Sultana J, Taylor JP, Ballard C; RENEWAL Study Group.

Alzheimers Res Ther. 2022 Nov 11;14(1):169. doi: 10.1186/s13195-022-01103-7.

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp KO, Glotfelty EJ, Li Y, Greig NH.

Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.

Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology

Gaertner Z, Azcorra M, Dombeck DA, Awatramani R.

Neurobiol Dis. 2022 Dec;175:105925. doi: 10.1016/j.nbd.2022.105925. Epub 2022 Nov 11.

Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease

Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY.

Neuroscience. 2022 Dec 15;507:139-148. doi: 10.1016/j.neuroscience.2022.11.001. Epub 2022 Nov 11.

[Role of β2-Adrenergic Receptor Agonist in the Cognitive Impairment Associated with Neurodegenerative Diseases]

Wang ZJ, Guo WN, Guo QZ, Wang S, Wang TJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Dec;44(6):1112-1116. doi: 10.3881/j.issn.1000-503X.14469.

Phase separation and other forms of α-Synuclein self-assemblies

Poudyal M, Sakunthala A, Mukherjee S, Gadhe L, Maji SK.

Essays Biochem. 2022 Dec 16;66(7):987-1000. doi: 10.1042/EBC20220055.

Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson's Disease Biomarkers, in Mammals

Hényková E, Kaleta M, Klíčová K, Gonzalez G, Novák O, Strnad M, Kaňovský P.

ACS Chem Neurosci. 2022 Dec 7;13(23):3230-3246. doi: 10.1021/acschemneuro.2c00516. Epub 2022 Nov 14.

P2X7 Receptor and Purinergic Signaling: Orchestrating Mitochondrial Dysfunction in Neurodegenerative Diseases

Zelentsova AS, Deykin AV, Soldatov VO, Ulezko AA, Borisova AY, Belyaeva VS, Skorkina MY, Angelova PR.

eNeuro. 2022 Nov 14;9(6):ENEURO.0092-22.2022. doi: 10.1523/ENEURO.0092-22.2022. Print 2022 Nov-Dec.

Ubiquitin-positive astrogliopathy clinically mimicking Parkinson's disease

Morris M, Moghekar A, Guo H, Pletnikova O, Redding-Ochoa J, Albert M, Resnick SM, Chen L.

Acta Neuropathol Commun. 2022 Nov 14;10(1):164. doi: 10.1186/s40478-022-01464-y.

Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson's Disease

Patel J, Panicker N, Dawson VL, Dawson TM.

CNS Drugs. 2022 Dec;36(12):1249-1267. doi: 10.1007/s40263-022-00973-7. Epub 2022 Nov 15.

The Thr105Ile Variant (rs11558538) of the Histamine N-methyltransferase Gene may be associated with Reduced Risk of Parkinson Disease: A Meta-analysis

Lu Y, Dong CZ, Bao D, Zhong C, Liu K, Chen L, Wang W, Yang B.

Genet Test Mol Biomarkers. 2022 Nov;26(11):543-549. doi: 10.1089/gtmb.2021.0299. Epub 2022 Nov 15.

Effects of Baduanjin exercise on motor function, balance and gait in Parkinson's disease: a systematic review and meta-analysis

Lai J, Cai Y, Yang L, Xia M, Cheng X, Chen Y.

BMJ Open. 2022 Nov 15;12(11):e067280. doi: 10.1136/bmjopen-2022-067280.

Sleep disturbance in caregivers of individuals with Parkinsonism: a systematic review and meta-analysis

Sprajcer M, Owen PJ, Crowther ME, Harper K, Gupta CC, Ferguson SA, Gibson RH, Vincent GE.

BMJ Open. 2022 Nov 15;12(11):e062089. doi: 10.1136/bmjopen-2022-062089.

 Reversible Pisa syndrome caused by chronic subdural hematoma in a patient with Parkinson's disease: a case report

Igami E, Fujimaki M, Shimizu M, Ishiguro Y, Kodama T, Okuma Y, Hattori N, Noda K.

BMC Neurol. 2022 Nov 15;22(1):432. doi: 10.1186/s12883-022-02972-z.

Prevalence of Rhinorrhea in Parkinson Disease: A Systematic Review and Meta-analysis

Chen T, Edwards TS, Hinson VK, Soler ZM.

Neurol Clin Pract. 2022 Aug;12(4):e75-e81. doi: 10.1212/CPJ.0000000000001180.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias